Anticancer Applications of Essential Oils Formulated into Lipid-Based Delivery Nanosystems DOI Creative Commons
Josef Jampílek, Katarína Kráĺová

Pharmaceutics, Год журнала: 2022, Номер 14(12), С. 2681 - 2681

Опубликована: Дек. 1, 2022

The use of natural compounds is becoming increasingly popular among patients, and there a renewed interest scientists in nature-based bioactive agents. Traditionally, herbal drugs can be taken directly the form teas/decoctions/infusions or as standardized extracts. However, disadvantages compounds, especially essential oils, are their instability, limited bioavailability, volatility, often irritant/allergenic potential. these active substances stabilized by encapsulation administered nanoparticles. This brief overview summarizes latest results application nanoemulsions, liposomes, solid lipid nanoparticles, nanostructured carriers used drug delivery systems oils for individual secondary metabolites applicable cancer therapy. Although discussed agents not typical anticancer agents, after inclusion into aforesaid formulations improving stability bioavailability and/or therapeutic profile, they indicated anti-tumor activity became interesting with treatment In addition, co-encapsulation synthetic nanoformulations aim to achieve synergistic effect chemotherapy discussed.

Язык: Английский

Hybrid exosomes, exosome-like nanovesicles and engineered exosomes for therapeutic applications DOI
Jagannath Mondal, Shameer Pillarisetti, Vijayabhaskarreddy Junnuthula

и другие.

Journal of Controlled Release, Год журнала: 2022, Номер 353, С. 1127 - 1149

Опубликована: Дек. 26, 2022

Язык: Английский

Процитировано

162

Nanoparticle-Based Delivery Systems for Vaccines DOI Creative Commons
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang

и другие.

Vaccines, Год журнала: 2022, Номер 10(11), С. 1946 - 1946

Опубликована: Ноя. 17, 2022

Vaccination is still the most cost-effective way to combat infectious illnesses. Conventional vaccinations may have low immunogenicity and, in situations, only provide partial protection. A new class of nanoparticle-based has shown considerable promise addressing majority shortcomings traditional and subunit vaccines. This due recent breakthroughs chemical biological engineering, which allow for exact regulation nanoparticle size, shape, functionality, surface characteristics, resulting improved antigen presentation robust immunogenicity. blend physicochemical, immunological, toxicological experiments can be used accurately characterize nanovaccines. narrative review will an overview current scenario nanovaccine.

Язык: Английский

Процитировано

131

Polymeric Micellar Systems—A Special Emphasis on “Smart” Drug Delivery DOI Creative Commons
Irina Neguț, Bogdan Biță

Pharmaceutics, Год журнала: 2023, Номер 15(3), С. 976 - 976

Опубликована: Март 17, 2023

Concurrent developments in anticancer nanotechnological treatments have been observed as the burden of cancer increases every year. The 21st century has seen a transformation study medicine thanks to advancement field material science and nanomedicine. Improved drug delivery systems with proven efficacy fewer side effects made possible. Nanoformulations varied functions are being created using lipids, polymers, inorganic peptide-based nanomedicines. Therefore, thorough knowledge these intelligent nanomedicines is crucial for developing very promising systems. Polymeric micelles often simple make high solubilization characteristics; result, they seem be alternative other nanosystems. Even though recent studies provided an overview polymeric micelles, here we included discussion on “intelligent” from We also summarized state-of-the-art most micellar respect treatments. Additionally, gave significant attention clinical translation potential treatment various cancers.

Язык: Английский

Процитировано

81

Wound healing strategies based on nanoparticles incorporated in hydrogel wound patches DOI Creative Commons
Paulami Dam, Merve Celik, Merve Ustun

и другие.

RSC Advances, Год журнала: 2023, Номер 13(31), С. 21345 - 21364

Опубликована: Янв. 1, 2023

Nanoparticle-modified hydrogels exhibit substantial promise in the realm of wound healing, with their ability to expedite tissue regeneration, mitigate infection risks, and facilitate enhanced therapeutic outcomes.

Язык: Английский

Процитировано

50

Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers DOI Creative Commons
Girish Kumar, Tarun Virmani, Ashwani Sharma

и другие.

Pharmaceutics, Год журнала: 2023, Номер 15(3), С. 889 - 889

Опубликована: Март 9, 2023

Anticancer drugs in monotherapy are ineffective to treat various kinds of cancer due the heterogeneous nature cancer. Moreover, available anticancer possessed hurdles, such as drug resistance, insensitivity cells drugs, adverse effects and patient inconveniences. Hence, plant-based phytochemicals could be a better substitute for conventional chemotherapy treatment properties: lesser effects, action via multiple pathways, economical, etc. Various preclinical studies have demonstrated that combination with is more efficacious than individually because plant-derived compounds lower efficacy drugs. suffer from poor aqueous solubility reduced bioavailability, which must resolved Therefore, nanotechnology-based novel carriers employed codelivery These include nanoemulsion, nanosuspension, nanostructured lipid carriers, solid nanoparticles, polymeric micelles, dendrimers, metallic carbon nanotubes provide benefits improved solubility, higher efficacy, dose, dosing frequency, bioavailability compliance. This review summarizes cancer, therapy deliver

Язык: Английский

Процитировано

43

Cancer Nanovaccines: Nanomaterials and Clinical Perspectives DOI
Nimeet Desai, Vivek P. Chavda, Thakur Raghu Raj Singh

и другие.

Small, Год журнала: 2024, Номер 20(35)

Опубликована: Май 1, 2024

Abstract Cancer nanovaccines represent a promising frontier in cancer immunotherapy, utilizing nanotechnology to augment traditional vaccine efficacy. This review comprehensively examines the current state‐of‐the‐art nanovaccine development, elucidating innovative strategies and technologies employed their design. It explores both preclinical clinical advancements, emphasizing key studies demonstrating potential elicit robust anti‐tumor immune responses. The study encompasses various facets, including integrating biomaterial‐based nanocarriers for antigen delivery, adjuvant selection, impact of nanoscale properties on performance. Detailed insights into complex interplay between tumor microenvironment responses are provided, highlighting challenges opportunities optimizing therapeutic outcomes. Additionally, presents thorough analysis ongoing trials, presenting snapshot landscape. By curating latest scientific findings developments, this aims serve as comprehensive resource researchers clinicians engaged advancing immunotherapy. Integrating design holds immense promise revolutionizing treatment paradigms, provides timely update evolving landscape nanovaccines.

Язык: Английский

Процитировано

24

Recent advancements in nanoconstructs for the theranostics applications for triple negative breast cancer DOI Creative Commons
Ashutosh Gupta, Kumar Nishchaya, Moumita Saha

и другие.

Journal of Drug Delivery Science and Technology, Год журнала: 2024, Номер 93, С. 105401 - 105401

Опубликована: Янв. 25, 2024

Cancer is a major public health concern worldwide; it the second-highest cause of death in United States. According to projections cancer incidence and mortality rates throughout world for year 2023, triple-negative breast (TNBC) expected be leading related among women worldwide. Traditional strategies treatment TNBC have many drawbacks, such as drug resistance, toxicity etc. Discovering novel delivery techniques researching innovative, efficient methods important. This review discusses types subtypes TNBC. The problems associated with standard therapies, mechanism resistance highlights need develop therapeutic strategies. It provides information on relative prevalence severity cancer. Several approaches viz. targeted therapy, gene bacterial-mediated nanomedicine, immune checkpoint inhibitors, theranostic, radiotherapy, chemotherapy, immunotherapy, herbal AI-based TNBC, are discussed detail. Additionally, diagnostic techniques, including imaging biopsy, expression profiling, mammography, magnetic resonance imaging, ultrasound, computed tomography scan, positron emission immunohistochemistry, been effective treatment. in-depth analysis innovative individualized care serve patients better.

Язык: Английский

Процитировано

19

Chitosan or Cyclodextrin Grafted with Oleic Acid Self-Assemble into Stabilized Polymeric Micelles with Potential of Drug Carriers DOI Creative Commons
Igor D. Zlotnikov,

Dmitriy A. Streltsov,

Natalya G. Belogurova

и другие.

Life, Год журнала: 2023, Номер 13(2), С. 446 - 446

Опубликована: Фев. 4, 2023

Polymeric micelles combining the advantages of biocompatible poly- and oligosaccharides with classical micellar amphiphilic systems represent a promising class drug carriers. In this work, based on chitosan (or cyclodextrin) oleic acid various modification degrees were synthesized-the most optimal grafting degree is 15-30% in terms CMC. According to NTA data, have hydrodynamic diameter main fraction 60-100 nm. The inclusion antibacterial agents: moxifloxacin or rifampicin was studied by FTIR spectroscopy fluorescence using pyrene label (using monomer-excimer approach). When aromatic molecules are incorporated into micelles, absorption bands C-H bonds fatty tails shift towards smaller wavenumbers, indicating stabilization structure, microenvironment molecule changes according low frequencies intensity oscillation 1450 cm-1 corresponding fragment. Loading leads change fluorescent properties: maximum emission long-wavelength region an increase anisotropy due drastic volume fluorophore-containing rotating Using label, critical micelle concentrations determined: from 4 30 nM depending polymer composition. Micellar enhance effect antibiotic increasing penetration bacterial cells storing protective coat. As part supramolecular remains active for more than four days, while free form, activity decreases after two days. pharmacokinetic experiments, vivo show 1.7 times efficiency compared form; moreover, higher maximal concentration blood achieved. advantage comparison simple cyclodextrins chitosan, which do not so significantly contribute parameters, shown. Thus, polymeric one key approaches improving effectiveness drugs solving problems resistant infections multidrug resistance.

Язык: Английский

Процитировано

30

Chitosan-Based Nano-Smart Drug Delivery System in Breast Cancer Therapy DOI Creative Commons
Yedi Herdiana, Nasrul Wathoni,

Dolih Gozali

и другие.

Pharmaceutics, Год журнала: 2023, Номер 15(3), С. 879 - 879

Опубликована: Март 8, 2023

Despite recent advances, cancer remains the primary killer on a global scale. Numerous forms of research have been conducted to discover novel and efficient anticancer medications. The complexity breast is major challenge which coupled with patient-to-patient variations heterogeneity between cells within tumor. Revolutionary drug delivery expected provide solution that challenge. Chitosan nanoparticles (CSNPs) prospects as revolutionary system capable enhancing activity reducing negative impacts normal cells. use smart systems (SDDs) delivering materials improve bioactivity NPs understand intricacies has garnered significant interest. There are many reviews about CSNPs present various points view, but they not yet described series in therapy from cell uptake death. With this description, we will more complete picture for designing preparations SDDs. This review describes SDDSs, targeting stimulus response using their mechanism. Multimodal chitosan SDDs medication therapeutic results.

Язык: Английский

Процитировано

30

The potential role of nanomedicine in the treatment of breast cancer to overcome the obstacles of current therapies DOI Creative Commons
Fan Yang,

Qingjie He,

Xiangpeng Dai

и другие.

Frontiers in Pharmacology, Год журнала: 2023, Номер 14

Опубликована: Фев. 22, 2023

Breast cancer (BC) is the most frequently diagnosed malignant tumor among women in world. BC heterogeneous with different subtypes including luminal A-like, B-like (HER2-/HER2+), HER2 enriched, and triple-negative BC. The therapeutic strategies surgery, chemotherapy, radiotherapy, targeted therapy, endocrine therapy are well developed commonly used treatment of However, some adverse effects these conventional treatments limited their wide application clinical. Therefore, it necessary to develop more safe efficient individualized Nanomedicine, as promising strategy for controlled drug delivery, widely multiple aspects therapy. Importantly, accumulative evidences show that nanomedicine has achieved good outcomes a huge amount patients benefited from related treatments. In this review, we summarized discussed major problems occurred during administration potential roles promoting efficacy by overcoming obstacles current

Язык: Английский

Процитировано

27